Investors feel optimistic about Quest Diagnostics' strength in Advanced Diagnostics. Robust base business volumes are also encouraging.

StockNews.com upgraded shares of Quest Diagnostics (NYSE:DGX – Free Report) from a hold rating to a buy rating in a research report released on Thursday morning. Other equities research analysts have ...

Upon finding out that he had high levels of PFAS chemicals in his private drinking water well in the Cadillac industrial park ...

Out of the 30 companies tracked by 360Dx, 22 saw their share prices decline, seven saw their stock prices increase, and one company’s shares remained essentially flat.

Mirae Asset Global Investments Co. Ltd. grew its stake in shares of Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 38.1% in the third quarter, according to the company in its most recent ...

Several new studies appear to confirm the test's potential to prevent overtreatment of melanoma patients while identifying those at high risk.

Several new studies appear to confirm the test's potential to prevent overtreatment of melanoma patients while identifying those at high risk.

Function's platform enables access to lab tests, available for $500 and HSA-eligible, that measure the heart, hormones, ...

What Happened: Kuppusamy's recent move involves selling 1,775 shares of Quest Diagnostics. This information is documented in a Form 4 filing with the U.S. Securities and Exchange Commission on ...

California is experiencing a fall wave of highly pathogenic avian influenza — or H5N1 — among dairy and poultry operations.

The North America genetic testing services market is expected to reach US$ 4.98 billion by 2030; it is estimated to register a CAGR of 15.2% from 2022 to 2030 by major factors driving includes the ...

The World Health Organization said on Wednesday it has listed two additional mpox in-vitro diagnostic tests for emergency use ...